Pacific Heights Asset Management LLC Takes Position in Agilent Technologies, Inc. $A

Key Points

• Pacific Heights Asset Management acquired 150,000 Agilent shares during the second quarter, valued at approximately $19.9 million and representing about 0.05% of the company.
• Agilent reported strong fiscal Q3 results, with revenue up 8.1% year over year to $1.88 billion and adjusted EPS of $1.62, beating analyst expectations. The company also raised its fiscal 2026 outlook to adjusted EPS of $6.18–$6.21 and revenue of approximately $7.5 billion.
• Analyst sentiment improved after the results, with several firms raising price targets and the stock carrying a consensus “Moderate Buy” rating. However, shares are near their 52-week high and trade at a relatively elevated valuation of about 31 times earnings.

Pacific Heights Asset Management LLC acquired a new stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 150,000 shares of the medical research company's stock, valued at approximately $19,924,000. Pacific Heights Asset Management LLC owned approximately 0.05% of Agilent Technologies as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Brighton Jones LLC raised its position in Agilent Technologies by 6.1% in the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company's stock valued at $626,000 after purchasing an additional 270 shares during the last quarter. Jones Financial Companies Lllp raised its holdings in Agilent Technologies by 15.9% in the 1st quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company's stock valued at $602,000 after buying an additional 769 shares during the last quarter. Geneos Wealth Management Inc. raised its holdings in Agilent Technologies by 54.8% in the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company's stock valued at $70,000 after buying an additional 212 shares during the last quarter. Acadian Asset Management LLC grew its holdings in Agilent Technologies by 16.5% during the 1st quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company's stock worth $625,000 after acquiring an additional 758 shares during the last quarter. Finally, Sivia Capital Partners LLC acquired a new position in Agilent Technologies in the 2nd quarter valued at approximately $273,000.

Key Stories Impacting Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 revenue of $1.88 billion, up 8.1% year over year and ahead of the $1.84 billion consensus estimate. Adjusted EPS was $1.62, beating expectations of approximately $1.49 and rising from $1.37 a year earlier. Operating profit, cash flow and margins also improved. Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: The company raised its fiscal 2026 outlook to adjusted EPS of $6.18-$6.21, above the $6.06 analyst consensus, and projected approximately $7.5 billion in revenue versus expectations of $7.4 billion. Management cited improving demand for laboratory instruments used in research and drug development. Agilent raises annual profit forecast on improving lab tools demand
• Positive Sentiment: Analyst sentiment strengthened significantly following the results. Citigroup and JPMorgan raised their price targets to $190, while RBC lifted its target to $185. Barclays, Stifel, Goldman Sachs, Bank of America, TD Cowen and Bernstein also raised targets, with most assigning Buy, Overweight or Outperform ratings. The revised targets imply roughly 11%-21% potential upside from the referenced trading level. Analyst price-target revisions
• Neutral Sentiment: Agilent is trading near its 52-week high and above both its 50-day and 200-day moving averages. That momentum supports investor confidence, although the stock’s valuation—around 32 times earnings and a PEG ratio above 2.7—leaves less room for disappointment.
• Neutral Sentiment: Institutional positioning was mixed in the latest filings: 594 investors added shares while 550 reduced holdings. Significant purchases by FMR, JPMorgan, Bank of New York Mellon and T. Rowe Price were offset by large sales from several other institutions.

Wall Street Analyst Weigh In

Several analysts recently weighed in on A shares. Weiss Ratings raised shares of Agilent Technologies from a "hold (c-)" rating to a "hold (c)" rating in a research note on Tuesday, June 2nd. Robert W. Baird lifted their target price on Agilent Technologies from $155.00 to $156.00 and gave the stock an "outperform" rating in a report on Tuesday, May 26th. JPMorgan Chase & Co. upped their price target on Agilent Technologies from $180.00 to $190.00 and gave the company an "overweight" rating in a research report on Thursday. TD Cowen increased their price target on Agilent Technologies from $155.00 to $180.00 and gave the company a "buy" rating in a research note on Thursday. Finally, The Goldman Sachs Group increased their price objective on shares of Agilent Technologies from $155.00 to $175.00 and gave the stock a "buy" rating in a research report on Thursday. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $170.33.

Agilent Technologies Stock Up 1.6%

Shares of Agilent Technologies stock opened at $157.60 on Friday. The stock's 50-day moving average is $139.76 and its 200 day moving average is $126.85. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $163.75. The firm has a market cap of $44.51 billion, a price-to-earnings ratio of 31.02, a PEG ratio of 2.74 and a beta of 1.25. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.13. The firm had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.84 billion. Agilent Technologies had a return on equity of 24.84% and a net margin of 19.53%.The company's revenue was up 8.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Equities research analysts anticipate that Agilent Technologies, Inc. will post 6.05 EPS for the current year.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source